Philips completes cancellation of 30.0 million shares
June 26, 2019
Amsterdam, The Netherlands ? Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it has completed the cancellation of 30,000,000 of its shares. The cancelled shares were acquired as part of Philips' recently completed EUR 1.5 billion share repurchase program that started in the third quarter of 2017, and of Philips' ongoing EUR 1.5 billion share repurchase program that started in the first quarter of 2019. Further details on the repurchase program can be found here.
Philips' current issued share capital amounts to EUR 181,055,015.40, representing 905,275,077 common shares.
For further information, please contact:
Ben Zwirs Philips Group Press Office Tel.: +31 6 1521 3446 E-mail: [email protected]
About Royal Philips Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at http://www.philips.com/newscenter.
The Industrial Technology Research Institute (ITRI) convened the 2024 ITRI Net Zero Day in Taipei, accelerating industry's transition to net-zero emissions. The event highlighted key innovations and successful business cases, focusing on the...
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...
Bristow Group Inc. , the global leader in innovative and sustainable vertical flight solutions, today announced it will release its first quarter 2024 financial results and selected financial outlook for 2025 and 2026 after market close on Tuesday,...
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...
SUNRATE, an intelligent global payment and treasury management platform has been named one of the Top 100 Cross-Border Payment Companies for 2024 by FXC Intelligence, which recognises and celebrates the most important players in the cross-border...